The National Institutes of Health (NIH) remains the primary federal agency responsible for conducting and supporting medical research in the United States. It allocates research funding through various mechanisms, with the study section peer review system being one of the key methods. This system
The recent selection of health officials by President-elect Donald Trump marks a significant shift in the U.S. approach to public health, with many of these nominees having been openly critical of the Biden administration's handling of the COVID-19 pandemic. This notable trend underscores a broader
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has garnered notable attention from various research firms recently, leading to an overall consensus rating of "Moderate Buy." The evaluation by these firms reflects a mixture of ratings, with one analyst assigning a hold rating and five others issuing a buy
In a groundbreaking study conducted by researchers at the Peter Doherty Institute for Infection and Immunity, a significant discovery has been made, revealing a novel mechanism by which the body regulates a type of immune cell known as unconventional T cells. These cells are pivotal in mounting
As the Trump administration took the reins of power, the health care industry faced a period of unprecedented uncertainty, driven by the potential impacts of new policies on various sectors, including hospitals and pharmaceuticals. With the Republicans gaining control of the White House and
The healthcare landscape is evolving, with a growing emphasis on treating the "whole person" rather than just addressing physical symptoms. This shift is particularly evident in the Veterans Health Administration (VA), which is adopting a "Whole Health" approach to better meet the comprehensive
